simulx software version 2021 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
simulx software version 2021
Simulx Software Version 2021, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simulx+version+2021/simulx+software+version+2021/pm36472169-70-29-34
Average 90 stars, based on 1 article reviews
Simulx Software Version 2021, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simulx+version+2021/simulx+software+version+2021/pm36472169-70-29-34
Average 90 stars, based on 1 article reviews
simulx software version 2021 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients. Article Snippet: 4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic Institute of Clinical Biochemistry, University Hospital Hradec Kralove and Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic Department of Clinical Pharmacy, Hospital Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic Department of Clinical Microbiology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic Concentration Assay:Article Title: Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients Article Snippet: .. Monte Carlo simulations (250 replicates of the original dataset) based on the final population PK model were performed to generate the theoretical distribution of areas under the vancomycin concentration–time curves (AUC) during initial treatment (first 60 h) using Article Title: Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections Article Snippet: .. Monte Carlo simulations (500 replicates of all the individuals in dataset) based on a final population PK model of oxacillin were performed to generate theoretical distribution of unbound oxacillin plasma concentration profiles over time using Article Title: Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Article Snippet: .. Monte Carlo simulations (500 replicates of all the individuals in dataset) based on a final population PK model of oxacillin were performed to generate theoretical distribution of unbound oxacillin plasma concentration profiles over time using Clinical Proteomics:Article Title: Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections Article Snippet: .. Monte Carlo simulations (500 replicates of all the individuals in dataset) based on a final population PK model of oxacillin were performed to generate theoretical distribution of unbound oxacillin plasma concentration profiles over time using Article Title: Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Article Snippet: .. Monte Carlo simulations (500 replicates of all the individuals in dataset) based on a final population PK model of oxacillin were performed to generate theoretical distribution of unbound oxacillin plasma concentration profiles over time using |